188 related articles for article (PubMed ID: 33084992)
1. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
3. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
5. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
[TBL] [Abstract][Full Text] [Related]
6. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
Ikuta S; Aihara T; Yamanaka N
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab.
Araki T; Tateishi K; Sonehara K; Hirota S; Komatsu M; Yamamoto M; Kanda S; Kuraishi H; Hanaoka M; Koizumi T
Thorac Cancer; 2021 Mar; 12(5):603-612. PubMed ID: 33434414
[TBL] [Abstract][Full Text] [Related]
8. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.
Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D
Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498
[TBL] [Abstract][Full Text] [Related]
9. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
[No Abstract] [Full Text] [Related]
11. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study.
Huang YY; Liu X; Liang SH; Hu Y; Ma GW
BMC Cancer; 2022 Nov; 22(1):1183. PubMed ID: 36397047
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
Takamori S; Takada K; Shimokawa M; Matsubara T; Fujishita T; Ito K; Toyozawa R; Yamaguchi M; Okamoto T; Yoneshima Y; Tanaka K; Okamoto I; Tagawa T; Mori M
Lung Cancer; 2021 Feb; 152():27-33. PubMed ID: 33341085
[TBL] [Abstract][Full Text] [Related]
13. The effect of platelet-to-lymphocyte ratıo (PLR) and glasgow prognostıc score (GPS) on recurrence, and survıval ın patıents undergoıng lobectomy for early-stage non-small cell lung cancer (NSCLC).
Agaoglu Sanli B; Gulmez B; Yazgan S; Ucvet A
Updates Surg; 2024 Apr; 76(2):631-639. PubMed ID: 37853294
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
Leung EY; Scott HR; McMillan DC
J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
[TBL] [Abstract][Full Text] [Related]
15. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.
Miyazaki T; Saji H; Nakamura H; Nagayasu T; Okumura N; Tsuchida M; Sonobe M; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M; Yoshino I;
Surg Today; 2022 Oct; 52(10):1463-1471. PubMed ID: 35211804
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
17. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Kishi T; Matsuo Y; Ueki N; Iizuka Y; Nakamura A; Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):619-26. PubMed ID: 26068494
[TBL] [Abstract][Full Text] [Related]
20. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
